Universities may jump to hire foreign researchers if Ottawa allocates funds to attract top talent | Unpublished
Hello!
Source Feed: The Globe and Mail
Author: Joe Friesen
Publication Date: November 2, 2025 - 07:00

Stay informed

Universities may jump to hire foreign researchers if Ottawa allocates funds to attract top talent

November 2, 2025

Canadian universities expect to be able to move quickly to hire researchers from abroad if the federal government announces new money to attract top scientists in the coming budget.

Universities have been waiting to see what direction the federal government will take as other countries have jumped on the potential hiring opportunity created by recent instability in U.S. academic funding.



Unpublished Newswire

 
Alberta Premier Danielle Smith pointed to her advisers when asked to explain how an Edmonton businessman whose contracts with the province’s health agency are now under scrutiny ended up in a hotel suite with her top lieutenants on the night of the 2023 provincial election. A Globe and Mail investigation published over the weekend examined the links between medical supply company executive Sam Mraiche and Ms. Smith’s government. The Globe found Mr. Mraiche, whose company MHCare was awarded more than $600-million in contracts with Alberta Health Services, had more extensive connections to...
December 1, 2025 - 22:01 | Matthew Scace, Emma Graney | The Globe and Mail
For now, Cole says he walks the perimeter of his home every night, checking for any unwanted visitors and hoping nothing like this happens again.
December 1, 2025 - 21:55 | Victoria Femia | Global News - Canada
More cases of prostate cancer were diagnosed at Stage 4 in recent years compared with about a decade earlier, a development that experts behind a new study suggest could be linked with official recommendations discouraging the use of a hotly debated screening test.The prostate-specific antigen test is a simple blood test that can serve as an early warning signal of cancer in men with no symptoms. But the test also has risks: It can lead to overdiagnosis and overtreatment of slow-growing prostate tumours that might never have caused harm had they remained undiscovered. For that reason, a...
December 1, 2025 - 20:45 | Kelly Grant | The Globe and Mail